This topic contains a solution. Click here to go to the answer

Author Question: A price-discriminating monopolist will tend to charge a lower price to students if it believes that ... (Read 37 times)

sam.t96

  • Hero Member
  • *****
  • Posts: 570
A price-discriminating monopolist will tend to charge a lower price to students if it believes that students:
 a. have a lower willingness to pay than other demanders.
  b. have a greater willingness to pay than other demanders.
  c. have very elastic demand curves.
 d. have nearly vertical demand curves.

Question 2

State two characteristics of the long-run equilibrium under perfect competition.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macybarnes

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

a

Answer to Question 2

In a long-run equilibrium (1) there are no firms outside the market that can earn an economic profit by entering it, and (2) no firms that are taking losses remain in the market.




sam.t96

  • Member
  • Posts: 570
Reply 2 on: Jun 30, 2018
Great answer, keep it coming :)


epscape

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library